FOXA:NASDAQFox Corporation Analysis
Data as of 2026-05-22 - not real-time
$64.26
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Fox Corporation (FOXA) is trading just above its short‑term moving averages, with the 20‑day SMA slightly below the current price and the 50‑day SMA just a touch lower. The MACD shows a bearish divergence, and the histogram is negative, suggesting downside pressure, while the overall trend remains neutral. Volume has been picking up, and the stock sits comfortably above a clear support zone but below a notable resistance level. Volatility over the past month is elevated, yet the beta remains low, indicating the share moves less than the broader market despite the price swings. The market sentiment index reads in the “Extreme Greed” territory, reflecting bullish investor appetite.
Fundamentally, the company posted a revenue dip year‑over‑year but delivered earnings per share well above consensus, driven by solid profit margins and a modest dividend payout. Cash generation exceeds debt obligations, and the payout ratio is comfortably low, supporting dividend sustainability. However, a discounted cash‑flow model places intrinsic value well below the current market price, flagging potential overvaluation. Analysts maintain a buy consensus, highlighting the forward earnings outlook and stable cash flow, while the dividend and defensive balance‑sheet traits add a value cushion.
Fundamentally, the company posted a revenue dip year‑over‑year but delivered earnings per share well above consensus, driven by solid profit margins and a modest dividend payout. Cash generation exceeds debt obligations, and the payout ratio is comfortably low, supporting dividend sustainability. However, a discounted cash‑flow model places intrinsic value well below the current market price, flagging potential overvaluation. Analysts maintain a buy consensus, highlighting the forward earnings outlook and stable cash flow, while the dividend and defensive balance‑sheet traits add a value cushion.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat with higher‑than‑expected EPS
- Bearish MACD divergence indicating near‑term downside risk
- Price positioned above support but below key resistance
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward earnings growth and low forward PE relative to peers
- Strong cash flow and low dividend payout ratio supporting sustainability
- Analyst consensus trending bullish with a buy recommendation
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue contraction raises concerns about top‑line momentum
- DCF valuation suggests the stock is priced well above intrinsic value
- Stable dividend and defensive balance sheet provide a defensive floor
Key Metrics & Analysis
Financial Health
Revenue Growth-8.60%
Profit Margin10.56%
P/E Ratio16.9
ROE15.20%
ROA8.71%
Debt/Equity67.87
P/B Ratio2.5
Op. Cash Flow$2.6B
Free Cash Flow$1.4B
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI52.0
Support$61.25
Resistance$68.25
MA 20$64.07
MA 50$61.87
MA 200$63.30
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5
Valuation
Fair Value$34.10
Target Price$73.88
Upside/Downside14.97%
GradeOvervalued
TypeBlend
Dividend Yield0.87%
Risk Assessment
Beta0.44
Volatility30.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.